Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00277-024-06095-y | DOI Listing |
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695442 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Correction to: Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia.
Ann Hematol
November 2024
Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.
Abnormal Weakening of DNA Methylation around the Gene Promoter in Temporal Lobe Epilepsy.
J Integr Neurosci
September 2024
Clinical Research and Experimental Center, Affiliated Hospital of Guangdong Medical University, 524001 Zhanjiang, Guangdong, China.
Article Synopsis
- The study investigates DNA methylation patterns of specific solute carrier genes linked to epilepsy in patients with temporal lobe epilepsy (TLE) and healthy controls.
- Results show that TLE patients have significantly lower DNA methylation rates compared to controls, which may help in developing predictive models for TLE.
- The findings indicate that reduced methylation could potentially lead to increased gene expression in TLE, but further research is needed to clarify the mechanisms involved.
Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
Ann Hematol
August 2023
Bristol Myers Squibb, Princeton, NJ, USA.
Erratum: Comparison between decitabine and azacitidine for patients with acute myeloid leukemia and higher-risk myelodysplastic syndrome: a systematic review and network meta-analysis.
Front Pharmacol
May 2023
Frontiers Media SA, Lausanne, Switzerland.
[This corrects the article DOI: 10.3389/fphar.2021.
View Article and Find Full Text PDFROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: Contributes to the progression of renal fibrosis.
Redox Biol
June 2023
Department of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, 250021, China. Electronic address:
Renal fibrosis is the common histopathological feature of chronic kidney diseases (CKD), and there is increasing evidence that epigenetic regulation is involved in the occurrence and progression of renal fibrosis. N-myc downstream-regulated gene 2 (NDRG2) is significantly down-regulated in renal fibrosis, the mechanism of which remains unclear. Previous studies have confirmed that the inhibition of NDRG2 expression in tumor cells is related to hyper-methylation, mainly regulated by DNA methyltransferases (DNMTS).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!